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Kinins are released from their plasma stores by enzymes derived from plasma 
or  other  fluids  such  as  saliva,  urine,  or  pancreatic  secretion  (1,  2).  Indirect 
evidence suggests  that  activation of kallikrein, the kinin-releasing enzyme in 
plasma, is an intermediate step in a  cascade reaction. However, the number of 
components reacting in the sequence and their order of participation has been 
uncertain.  In  addition,  the  participation  of  the  kinin-forming  system  in  in- 
flammatory injury has not been defined. In order to gain an understanding  of 
these unknown factors we have chosen to prepare each component of the system 
in precursor form. In this way, the number, sequence of interaction, and mode 
of activation may be assessed directly. We will detail here the preparation and 
characteristics of one of these components,  the kinin-generating enzyme,  as a 
single,  stable precursor.  Comparison  of physical parameters  of this precursor 
with active kallikrein shed some llght on the mode of activation of this plasma 
proenzyme. 
Malerials and Methods 
Rabbit Blood.--Rabbits were bled from the ear artery with siliconized needles. The blood 
was collected in polypropylene  centrifuge tubes containing acid-citrate  dextrose anticoagulant, 
pH 6.8. The cells were removed by centrifugation at 3500 rpm for 40 min. Plasma globulins 
were treated with neutralized and saturated ammonium  sulfate containing 0.001 ~t ethylene- 
diaminetetraacetic acid  (EDTA)  and hexadimethrine bromide 50 ~g/ml at 4°C. Globulins 
soluble at 33%  saturation and insoluble at 50% saturation were obtained for further study. 
Heaadimethrine Bromide.--Hexadimethrine  bromide  (HBr, 1 Aldrich Chemical  Co.,  Inc., 
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Milwaukee, Wis.) was stored at 4°C under vacuum with desication and was dissolved in dis- 
tilled water to make a stock solution of 10 mg/ml. HBr 50 t~g/ml was used to treat surfaces 
with which  the plasma globulins for preparative  chromatography were exposed.  Dialysis 
membranes, anion exchangers, gel filtration media, and Pevikon (Pharmacia Fine Chemicals, 
Uppsala, Sweden) were rinsed thoroughly with HBr for 1 hr and then washed thoroughly. 
Glassware.--All glassware was treated with a siliconizing agent (Siliclad, Clay-Adams, Inc., 
Parsippany, N.  J.)  and  oven dried.  Plastic test tubes, columns, vessels,  and pipettes were 
employed whenever possible. 
Standard Buffers.--Commonly used isotonic buffers were 0.15 M sodium chloride buffered 
with 0.01  ~  phosphate, pH  7.4  (phosphate-buffered saline,  PBS),  or buffered with 0.01 ~t 
tris (hydroxymethyl) aminomethane (Tris),  pH 7.4  (Tris-buffered saline,  TBS). 
Anion Exchange Chromatography.--Diethylaminoethyl  (DEAE)-Sephadex A-50  (Pharma- 
cia)  3.5 -4- 0.5 mEq/g was hydrated, charged, and equilibrated with 0.0075 ~ phosphate and 
0.001 M EDTA, pH 8. The final ionic strength was 0.01 u. The anion exchanger was packed 
into plastic 3.7  X  75-cm columns by gravity. 
Protein solutions for chromatography were dialyzed, applied to the column, and 100 ml of 
buffer was allowed to flow in. The rate of flow was maintained with a pump (LKB Variperpex, 
Bromma, Sweden)  at 50 ml/hr. After excluded proteins eluted, a gradient of sodium chloride 
in phosphate-EDTA buffer was then commenced and the effluent  collected. 
Cation Exchange Chromatography.--Carboxymethyl  (CM)-Sephadex C-50, 4.5 mEq/g was 
hydrated and equilibrated with citrate-phosphate buffer, pH 6, ~  =  0.01.  The sample was 
applied to a 3.1  X  30 cm column of the gel and washed. Proteins were eluted with a linear 
gradient which utilized 0.25 M sodium chloride buffered with citrate-phosphate in the termi- 
nating vessel. 
Pez'ikon-Block Eleetrophoresis.--Electrophoresis in Pevikon (Pharmacia) was performed in 
a  standard fashion with 0.05 ~  phosphate, pH 8.0  (3). A constant voltage of 400 v was ap- 
plied for 20 hr. The block was then sectioned into 1-cm segments and proteins were recovered 
by eentrifugation. 
Gd Filtration.--Molecular  sieving was carried out  on  4  X  f00-cm columns of hydrated 
Sephadex G-200 (Pharmacia). The void volume was determined by blue colored 2  X  106 mol 
wt dextran and the internal volume of the gels calibrated with marker substances whose dif- 
fusion coefficients and molecular weight were known. The eluting buffer was PBS with a con- 
stant flow rate of 8-12 ml/hr. 
Isoelectric Foeusing.--Isoelectric  point determination  s were performed in siliconized  110-ml 
columns designed for this purpose (LKB). Appropriate ranges of polyampholytes establishing 
a range of 2 pI-I units, usually pH 5-7, were distributed in a (~45% sucrose gradient. The final 
ampholyte concentration was 2 g/100 ml. A constant voltage of 500-600  v was applied for 
30-48 hr; the temperature was held constant at 10°C. Fractions were collected, the pH deter- 
mined at 22°C, and the pH of aliquots adjusted by the addition of an equal volume of 0.1 
Tris buffer, pH 7.5, and when necessary, a drop of 0.5 N NaOH. 
~ltracentrijugation.--Preparative  and  analytical  ultracentrifugation was  carried  out  in 
linear gradients of sucrose dissolved in PBS or TBS as described elsewhere (4). 
Disc-Gel Electrophoresis.--Polyacrylamide-gel electrophoresis  was carried out with materials 
and buffers described by Davis (5). Gels were stained for protein with Coomassie brilliant blue 
lyslne methyl ester; OMTI,  ovonmcoid trypsin inhibitor; PAS, periodic acid-Schiff; PBS, 
phosphate-buffered saline; PKA, prekallikrein activator; PMSF, phenyI methyl sulfonyl flu- 
oride; Rm, relative mobility; SBTI, soya bean trypsin inhibitor; SDS, sodium dodecyl sulfate; 
rIBS,  Tris-buffered saline; TLCK,  tolsyl lysine chloromethyl ketone; TLMe,  tolsyl lysine 
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in 10% trichloroacetic acid  (TCA). In some instances, proteins were recovered from the gel 
by eluting successive 2-ram segments of an unstained gel in TBS 0.2 ml overnight at 4°C. 
Sodium  Dodecyl Sulfate  (SDS)-Acrylamide-Gd  Electrophoresis.--Molecular  weight  deter- 
minations of prekallikrein incubated with buffer or the prekallikrein activator were determined 
by SDS-acrylamide-gel electrophoresis (6). Acrylamide 10% and cross-linker 0.2% were used 
without disulfide reducing agents. After electrophoresis at 8 ma/tube for 4 hr, the gels were 
stained with Coomassie brilliant blue  (7)  or placed on dry ice until firm and cut with a gel 
slicer into 1.3-mm segments. 
Glycoprotein (PAS)  Staining  Procedure.--After  electrophoresis in  SDS-acrylamide  gels, 
glycoprotein was  demonstrated  by  the periodic  acid-Schiff  (PAS)  method.  Proteins  were 
fixed in the gel by several changes of 7% acetic acid: 50% methanol (1:1) for 24 hr. After 
further washing with 7% acetic acid, the gel was placed in 0.2% periodic acid for 1 hr. The 
gel was again washed with three changes of acetic acid for 6 hr and placed in the Feulgen 
reagent for 30 rain. The gel was then photographed and the relative mobility (Rm)  of PAS- 
reactive bands was measured. 
Radioiodination.--Prekallikrein  was trace radiolabeled with 125I by a  modification of the 
chloramine-T method  (8). 
Kinin Assay.---Quantitation  of kinins was determined by bioassay on the estrus rat uterus. 
The amplitude of contractions of unknown samples was recorded on a moving chart (Phipps 
&  Bird,  Inc.,  Richmond,  Va.)  and  compared  to  given quantities of  synthetic bradykinin 
(BRS 640, Sandoz Ltd., Base]) in Tyrode's solution containing 0.1% gelatin. Samples which 
contained  kinins  were  also  treated  with  chymotrypsin  (Nutritional  Biochemicals  Corp., 
Cleveland, Ohio) 10 ~g/ml, or carboxypeptidase B  (Worthington Biochemical Corp., Freehold, 
N. J.) 10 ug/ml, for 15 rain at 37°C  and reassayed. 
Kininogen Assay.--Quantitation  of kininogen was determined by the amount of kinin re- 
leased and expressed as equivalents of synthetic bradykinin as measured by bioassay. Aliquots 
of 0.25 ml containing kininogen were buffered at pH 7.5 with 0.1 ~ Tris, treated with trypsin 
25 t~g, and incubated for 1 hr at 37°C; the volume was then brought to 2 ml with buffer and 
assayed. 
Separate tests were performed on 0.25-ml aliquots of kininogen to determine whether kini- 
nase or inhibitors of trypsin or kallikrein were present in the preparation. Isolated kininogen 
was free of these interfering substances. During preparation of kininogen, however, they could 
be measured to varying degree. When necessary, kininase was inhibited by treatment of the 
test mixture with 8-hydroxyquinoline to a final concentration of 1 mg/ml. An excess of trypsin 
was used when trypsin inhibitors were found. 
Kallikrein  Assay.--The  kinin-releasing enzyme was  measured  by  release  of  kinin from 
isolated kininogen or hydrolysis of synthetic amino acid esters.  (a) The kinin-generating ac- 
tivity of kallikrein was determined with purified kininogen (9). To 0.25 ml of kininogen con- 
taining 250- to 1000-ng equivalents, buffered to pH of 7.5,  0.1 ml of kallikrein was added. 
After incubation at 37°C for 30 rain, the reaction was stopped by addition of 100 ug of soya 
bean trypsin inhibitor (SBTI), the volume brought to 2 ml, and assay for free kinin carried 
out.  Controls included reagents mixed but not allowed to incubate, as well as each reagent 
incubated alone. 
(b)  A rapid, accurate quantitative determination of kallikrein was performed by differen- 
tial spectrophotometry  (10) with benzoyl arginine ethyl ester  (BAEe). Samples were added 
to 3.0 ml of a  solution containing 1 mmole BAEe/liter in 0.15 M sodium chloride buffered 
with 0.01  M Tris, pH 7.6.  Mter incubation at 37°C  for specific  time intervals, the increased 
absorbance at 253  nmole due to hydrolysis of BAEe was compared to known quantities of 
benzoyl-L-arginine. The amount  of enzyme giving hydrolysis of  1 ~mole/min at  37°C  was 
taken as 1 unit (U). 
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high voltage paper electrophoresis. In all instances, the amino acids were of the L-configuration 
and substitution was in the N-alpha position when pertinent.  The following substrates were 
purchased  (Cyclo Chemical Corp., Los Angeles,  Calif., or Mann  Research Chemicals, New 
York) : acetyl lysine amide (ALA), acetyl glycyl lysine methyl ester (AGLMe), lysine methyl 
ester (LMe), acetyl lysine methyl ester (ALMe), benzoyl lysine methyl ester (BLMe), carbo- 
benzoxy lysine methyl ester (CBZLMe), and tolsyl lysine methyl ester  (TLMe). 
Synthetic substrates  0.05  ~I were prepared  in 0.l  •  phosphate  buffer,  pH  7.5. To  10 ~1 
substrate was added 0.5 ~g kallikrein in 50 ~1 PBS. The reaction mixture was allowed to incu- 
bate at room temperature  (22°-25°C)  and  10 vl spotted on Whatman chromatography paper 
46 X  57 cm after varying intervals of time. The paper was moistened with pyridine-acetate 
buffer, pH 6.4, and electrophoresis carried out to the cathode at 1200 v for 75 rain. The paper 
was dried at 65°C and stained with a solution of ninhydrin 2% in acetone. Comparison of the 
degree of hydrolysis at standard  time intervals, usually I, 3, and 5 hr allowed a relative com- 
parison of the rate of hydrolysis with different substrates. 
Prekalllkrein Assay.--Prekallikrein required activation for enzymatic detection. Quantita- 
tive estimation of this proenzyme, when activated, was the same as for kallikrein. 
Activation  of Prekallikrein.--Activation was carried  out with the prekallikrein activator 
isolated frmn plasma or with trypsin. The prekallikrein activator (PKA) was isolated in highly 
purified form from rabbit or human plasma  (1l, 12). PKA in TBS, 0.1 ml, was added to ali- 
quots of prekallikrein, incubated at 37°C for 30 rain,  and the reaction stopped by addition of 
lima bean trypsin inhibitor (LBTI)  100 ~zg in 0.1  ml. As PKA does not hydrolyze BAEe or 
directly release kinin from kininogen, this activator did not interfere in these tests for kallikrein. 
Tr)~psin  (2  X  crystallized,  Worthington Biochemicals) was dissolved in 0.001 M HC1 at 
1 mg/ml. Before use, the trypsin was diluted in 0.1 ~ Tris buffer,  pH 7.5. In a typical experi- 
ment,  0.1-0.3  ml aliquots of a  sample or fraction believed to contain prekallikreiD,  0.1  ml 
tr)-psin (1--4 ~g) at pH 7.5 were incubated at 37°C for 15 rain.  At the end of incubation, lima 
bean trypsin inhibitor (Wmthington Biochemicals) 100 ug in 0.1 ml was added to inhibit the 
trypsin. Controls included tD~psin alone,  trypsin with LBTI, and untreated prekallikrein. 
Other substances investigated for the ability to activate prekallikrein were bovine thrombin 
(Parke, Davis & Co., Detroit, Mich.) and chymotrypsin (Worthington Biochemicals). Human 
C~ was a gift from Dr. Nell Cooper. 
Hydrolysis  of Protein Subslrates.---Sohitions of 12~I-labeled proteins 4 mg/ml were mixed 
with kallikrein or trypsin 2 ug/ml or buffer and incubated at 37°C for 24 hr. The protein was 
then precipitated with TCA 10% and the 125I measured in precipitate and supernatant. 
RESULTS 
Isolalion  of Plasma  Prekallikrein.--Rabbit  arterial  blood  was  freest  of  cells 
and salted  out with ammonium  sulfate.  The globulin fraction,  soluble at  30 % 
saturation  and precipitated  at  50%  saturation,  was  dialyzed and  applied  to  a 
plastic  column  containing  DEAE-Sephadex  A-50.  The  elution  characteristics 
of prekallikrein obtained by a gradient of NaC1 are shown in Fig. 1. Prekallikrein 
eluted entirely in the precursor form since, before activation, fractions failed to 
liberate  kinin  from  functionally  purified  rabbit  kininogen  or  to  hydrolyze 
synthetic  substrates.  After activation  by trypsin  or the plasma  PKA,  a  single 
peak  of kallikrein  was  observed  in  fractions  eluting  at #  =  0.09.  The prekal- 
likrein  was  pooled  and  concentrated  by  precipitation  with  60%  ammonium 
sulfate. After overnight dialysis, the proteins were chromatographed on DEAE- 
Sephadex  A-50  at  pH  6.6.  Fractions  were  again  eluted  by  a  sodium  chloride KIRK  D.  WUEPPER  AND  CHARLES  G.  COCHRANE 
gradient  in  phosphate-EDTA  buffer.  Although  the  specific  activity  was  in- 
creased only slightly by rechromatography on DEAE-Sephadex (Table I), the 
requirement for hexadimethrine bromide no longer became necessarv. 
0.6 ¸ 
=  0.4 
-~  0.2.  :5 
o  [2oo  r 
I  [,75  ~,, 
=,6:  ,  ,  /  /  ~  t'0°~= 
•  ll  t  o 
~°'  /  /',~/~  \  __  Jl  t '°  ~o.,----=~~L~_ > t" 
20  '  ~'0  "  I00  '  140  '  ~Bo  '  220'  2~0  ''300  '  340 
Fraction  Nnrnber 
FIG. 1. Chromatography of ammonium  sulfate-precipitated globulins on DEAE-Sephadex 
A-50. A gradient of NaC1 to 0.25 ~, was developed in the starting buffer of phosphate-EDTA 
0.01 ~* beginning at arrow 1. The ionic strength was increased to 1.0 ~ with NaC1 beginning at 
arrow 2. After activation, kallikrein was quantitated hy BAEe hydrolysis. 
TABLE I 
Isolation  of Rabbit Plasma Prekallikrein:  Specific Activity, Degree 
of Purification,  and Per Cent Yield 
BAEe  Specific  Purification  Yield  Prekallikrein step  Volume  hydrolysis  Protein  activity 
ml  U/ml  mg/ml  U/mg  % 
Plasma  1400  1"  80.0  0.013  1"  100 
DEAE-Sephadex I  93  12.6  30.8  0.41  32  83.7 
DEAE-Sephadex II  144  5.8  12.4  0.47  36  59.6 
CM-Sephadex  176  2.6  0.2  13.0  1000  31.3 
Pevikon  14.6  5.7  0.07  81.0  6200  5.9 
* Estimated, 1 U/ml. 
The pooled fractions of prekallikrein were dialyzed against citrate-phosphate 
buffer and applied to a  column of CM-Sephadex C-80 equilibrated at pH 6.0. 
The elution of prekallikrein from the cation exchanger is given in Fig. 2. The 
kallikrein precursor eluted in  a  single peak at an ionic strength  of/~  =  0.14. 
The specific activity increased approximately 25-fold (Table I). PLASMA PREKALLIKREIN 
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Fro.  2.  Chromatography  on  CM-Sephadex  C-50  of prekallikrein pooled  from  anion  ex- 
change chromatography. After excluded proteins eluted, a gradient of NaC1 to 0.25 ~ was de- 
veloped in the starting  buffer  of citrate-phosphate  of 0.01 ~. After activation, kallikrein was 
quantitated  by BAEe hydrolysis and expressed  in units per milliliter. 
FIG. 3. Pevikon-block electrophoresis of prekallikrein pooled and dialyzed after cation ex- 
change  chromatography.  After treatment  with  the  prekallikrein  activator  or  trypsin  (see 
Materials and Methods), kallikrein was found to correspond to the smaller peak of protein. 
The  insert  shows  7.5%  acrylamide-gel electrophoresis  of  the  sample  applied  (CM-S)  and 
fractions 15,  18, and 21. 
The fractions containing prekallikrein from C3/I-Sephadex were concentrated 
to 6  ml by ultrafiltration,  dialyzed,  and  subjected to the final purification  pro- 
cedure,  electrophoresis  in  Pevikon.  The  results  are  depicted  in  Fig.  3.  The 
specific activity increased  to  81  BAEe U/mg  protein  (Table  I).  Prekallikrein KIRK  D.  WUEPPER  AND  CHARLES  G.  COCItRANE 
was  freed from  the  major  contaminating  protein,  gamma globulin,  and  cor- 
responded  to  a  small protein peak of "~1 electrophoretic mobility. Analysis of 
the  fractions  containing  prekallikrein  by  analytical  acrylamide-gel  electro- 
phoresis revealed a  single major band of protein in these fractions. Successive 
2-ram cuts from a  gel were eluted in buffer overnight and assayed before and 
after incubation with PKA with BAEe or functionally purified kininogen sub- 
strates. Kinin release and ester hydrolysis corresponded to the stained protein 
band (Fig. 4). 
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FIG. 4.  Polyacrylamide-gel electrophoresis 7.5%, pH 8.3, of isolated prekallikrein. The 
upper gel, stained for protein with Coomassie  blue in trichloroacetic acid, was cut at the track- 
ing dye; a parallel gel was cut in 2-ram segments, eluted, and tested for kallikrein and esterase 
activity with or without the addition of the prekatlikrein activator. 
The prekallikrein remained stable at 4°-8°C for several months in its highly 
purified form. No spontaneous activation occurred. Addition of PKA or trypsin 
activated predictable amounts of kallikrein activity. 
Activation of Prekallikrein.--Direct  activation of prekallikrein was performed 
by treatment with (a) highly purified PKA and (b) bovine pancreatic trypsin. 
When kallikrein activity was generated,  two activities were readily measured, 
namely, the hydrolysis of synthetic amino acid esters and the capacity to release 
a kinin from purified kininogen. As ester hydrolysis was rapidly and quantita- 
tively  performed  spectrophotometrically,  kallikrein  was  quantitated  by  this 
means  (vide  infra).  When  a  solution  of  isolated  prekallikrein  68  /zg/ml was PLASMA  PREKALLIKREIN 
TABLE  1I 
Act?, afion of Plasma Prekallikreln 
Substance  added  Amount added  Preallkikrein*  Incubation  BAEe hydrolysis 
rain  m,umvles/min 
None  +  0  2.4 
12  2.4 
PKA~  1.1  /~g  +  0  3.6 
6  103.6 
12  196.4 
PKA  0  55 #g  +  0  3.6 
6  64.3 
12  121.4 
PKA  1.1  #g  --  12  0.0 
Trypsin{  1 /~g  --  20  0.0 
Trypsin  1 ga  4.  0  2.6 
5  52.4 
10  74.5 
20  t)6.9 
Chymotrypsln{  2 #g  --  30  0.0 
2 Izg  4.  30  0.0 
0.5 #g  4.  30  0.0 
Thrombin§  2.5 U  --  30  33.3 
Thrombin  2.5 U  --  30  31.4 
1.3 U  4.  30  8.1 
C1 esterase§  10.6/~g  --  30  47.9 
C 1 esterase  10.6 #g  +  30  40.4 
5.3 #g  4"  30  25.3 
2.7 lzg  4"  30  14.7 
* Prekaliikrein was added (+) at 68 #g/ml, or substituted with TBS  (--). All incubations 
performed at 37°C, pH 7.5. 
After incubation with the prekallikrein activator (PKA), trypsin, or chymotrypsin, the 
reaction was stopped by addition of 100 Izg LBTI 0.1 ml. 
§ BAEe hydrolysis  was determined 30 rain after addition of thrombin or human C 1 esterase. 
No inhibitor was added. Ester hydrolysis did not increase over control values after incubation 
with these agents. 
treated with varying quantities of PKA  containing 0.5-1.0/~g in 50 #1  and the 
reaction stopped by transferring an  aliquot to  100 #g of LBTI,  kallikrein was 
generated as shown in Table II. The reaction was carried out at pH  7.4,  ionic 
3  o~  strength  of 0.l,  at.  7  C.  If  the  LBTI  was  added  immediately after  mixing, KIRK  D.  WUEPPER  AND  CHARLES  G.  COCHRANE 
kallikrein generation was  not observed. If the inhibitor was  added after ap- 
proximately 30 min, full activation could be measured, showing that LBTI was 
not inhibiting kallikrein. Hydrolysis of BAEe or kinin release from kininogen 
was not observed in controls of PKA incubated with buffer. 
The second substance shown to activate prekallikrein was trypsin. Addition 
of 1 #g of trypsin in 0.1 ml to prekallikrein rapidly generated activity in the 
preparation. The interfering effects of trypsin in hydrolysis of BAEe or release 
of kinin were eliminated by addition of LBTI or ovomucoid trypsin inhibitor 
(OMTI) 1 mg/ml. These inhibitors had no effect on the detection of kallikrein 
once formed. The time course of activation of a  solution containing 60 #g of 
prekallikrein/ml by 1 #g of trypsin is shown in Table II. 
Other enzymes were investigated to determine whether they could activate 
prekallikrein (Table II). These included (a)  bovine chymotrypsin, (b)  bovine 
thrombin,  and  (c)  human  Cls.  These substances  failed to activate  the pro- 
enzyme. 
The possibility of autoactivation was  investigated by incubating 0.5/~g  of 
kallikrein with 5/zg of prekallikrein; the mixture was sampled at 1, 2, and 6 hr. 
The reaction was held at neutral pH in PBS at 22°C; autoacfivation was not 
observed. 
Characterization of Plasma Prekallikrein.--Physical properties of prekallikrein 
and its active product were determined by gel filtration, sucrose gradient ultra- 
centrifugation, and isoelectric focusing in polyampholytes. The two substances 
were subjected to these procedures both singly and simultaneously without ap- 
parent difference. When  tested together, a  mixture of prekallikrein and kal- 
likrein was prepared so as to contain a 3- to 4-fold greater quantity of the pro- 
enzyme. The active enzyme was assayed first; then the precursor was activated 
and measured. When necessary, the values due to kallikrein were subtracted to 
determine the contribution for the proenzyme alone. 
Molecular sieve chromatography:  When prekallikrein and kallikrein were co- 
chromatographed on a calibrated 4  X  100 cm column of Sephadex G-200, the 
precursor consistently emerged approximately 8 ml before the kallikrein (Fig. 
5). IgG, bovine albumin, and equine heart cytochrome C, substances used to 
calibrate the column, were used to determine the diffusion coefficients of pre- 
kallikrein and kaUikrein (Fig. 6). When the log molecular weight was plotted 
as a function of the elution volume (13), the kallikrein had a mol wt approxi- 
mately 10,000-15,000 daltons less than its precursor. 
Ultracentrifugation:  Simultaneous ultracentrifugation of kallikrein and pre- 
kallikrein was performed in linear gradients of sucrose 5-25 % in PBS. A sample 
0.2  ml  to which  internal markers  IgG globulin-131I  and  bovine albumin  125I 
were added was  centrifuged at 45,000 rpm for 15  hr.  Based on known sedi- 
mentation rates for the marker substances  of 6.8  and 4.45,  respectively, the 
kallikrein was observed to sediment at 4.0S and the prekallikrein at 4.5S (Fig. 
7).  Assuming  a  partial specific volume of 0.73,  the molecular weights of the 10  PLASMA PREKALLIKREIN 
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FIG. 5. Gel filtration on Sephadex G-200 of a mixture of prekallikrein and kallikrein. The 
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two  substances  were  calculated  from  their  diffusion  and  sedimentation  co- 
efficients (Table III). For rabbit prekallikrein, the molecular weight was 99,800 
daltons; the kallikrein was 86,300 daltons. 
Isoelectric  focusing:  Prekallikrein  and  kallikrein  had  an  isoelectric  point 
between  5  and  6  when  these  substances  were  individually  focused  in  poly- 
ampholytes. Analysis of a mixture of the two substances containing  100 #g of 
prekallikrein and 35  #g of kallikrein is shown in Fig.  8. The isoelectric point 
was  determined  to  be 5.9-6.05  for prekallikrein  and  5.35-5.4  for  kallikrein. 
Chemical  Properties  of Prekallikrein.--Kallikrein  and  its  precursor  readily 
TABLE III 
Physical and Chemical Properties of Prekallikrein and Fragments Released by PKA 
Prekallikrein  Kallikrein  Fragment 
Electropboretic mobility  ")'1  71  ND* 
Sedimentation coefficient  4.5  4.0  0.9 
Diffusion coefficient  4.46  4.59  13.0 
(;< 10  -7 cm2/sec) 
Molecular weight: (a):~  99,900  86,300  6,900 
(b)  100,000  88,000  11,000 
(c)  102,000  91,000  11,600 
Isoelectric point  5.9  5.4  N D 
BAEe, U/mg protein  81  92  0 
* ND, not determined. 
(a) Calculated from S and D, v assumed 0.73; (b) SDS-gel electrophoresis; (c) determined 
on Sephadex G-150 by the method of Andrews (13). 
stained with the protein dyes Coomassie blue and Buffalo black and absorbed 
in  the  ultraviolet  region  characteristic  for  the  peptide  bond.  To  determine 
whether  prekallikrein-125I  contained  carbohydrate,  5-#g  quantities  were sub- 
jected  to  SDS  gel electrophoresis and stained  by the  PAS  method.  A  single 
band which stained with this procedure corresponded  (Rm 0.22)  to a  similar 
band in a separate gel stained with Coomassie blue and to the peak of nq label 
as determined in a third gel cut in 1.3-mm segments. 
Mechanism  of Prekallikrein  Activation.--In  order  to study  the  mechanism 
whereby  the  prekallikrein  activator  generates kallikrein  from its  precursor, 
products  of  this  interaction  were  resolved  by  SDS-acrylamide-gel  electro- 
phoresis and by ultracentrifugation.  Aliquots of prekallikrein-125I 5 /zg in 0.1 
ml were incubated with buffer or PKA 25 #1 containing approximately 0.5/~g 12  PLASMA PREKALLIKREIN 
of protein for 40 rain at 37°C. A  10 ~1 aliquot was then withdrawn from each 
tube  to  determine  that  activation  had  taken  place.  The  samples were  then 
mixed with  bromphenol blue,  glycerine,  and  SDS  0.1%  and  electrophoresed. 
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FIG. 9. SDS-acrylamide-gel  electrophoresis of prekallikrein-12aI incubated with buffer (left 
panel)  or PKA (rigkt panel). 
When  the gels were cut and the 12aI counts determined, the precursor was ob- 
served to be cleaved into two labeled moieties containing 90.5  and 9.5 %  of the 
label, respectively (Fig. 9). KIRK  D.  WUEPPER  AND  CHARLES  G.  COCHRANE  13 
When  the  log molecular weight was  plotted as  a  function of the Rm and 
compared with substances of known molecular weight (Fig. 10), kallikrein and 
the fragment released by PKA had tool wt of 88,000 and 11,000, respectively. 
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FzG. 10.  Molecular weights of prekallikrein and fragments released by PKA plotted as a 
function of relative mobility. The Rm of marker substances cytochrome c, egg white trypsin 
inhibitor, bovine albumin, and albumin dimer is the mean of four determinations. 
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FIG.  1 l. Sucrose gradient nltracentrifugation of prekallikrein-125I incubated with buffer or 
PKA. A third gradient contained marker substances IgG, albumin, and cytochrome c. 
Additional direct evidence for limited proteolysis of rabbit prekallikrein by 
PKA  was  obtained by gradient ultracentrifugation in  sucrose.  Prekallikrein- 
1~5I 10/~g  preincubated with buffer or with  PKA was  applied to the top of 
separate gradients of sucrose and sedimented. A third gradient contained marker 
substances. The results are given in Fig. 11. After activation, two labeled frag- 14  PLASMA  PREKALLIKREIN 
ments  sedimenting  at  4.2S  and  0.9S  were  observed.  Kallikrein  activity was 
associated with  the larger fragment. Unactivated prekallikrein sedimented at 
4.5S. 
Hydrolysis of Synthetic Substrates.--Isolated rabbit  plasma  kallikrein  hy- 
drolyzed  synthetic  amino  acid  substrates  of  arginine  and  lysine  at  pit  7.6. 
Product  formation was  measured  spectrophotometrically or  by high  voltage 
electrophoresis. 
The methyl or ethyl esters of N-o~-benzoyl-substituted arginine were superior 
snbstrates  for quantitation  of rabbit kallikrein.  Linear initial velocities were 
obtained when 0.63-6.25/zg  of kallikrein was added to BAEe 0.001  M at 25°C, 
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F1G. 12. Hydrolysis of mM BAEe pH 7.6, 25°C by varying amounts of rabbit plasma kalli- 
krein. Initial  velocities determined at minute intervals are shown in the insert. The molar 
extinction coefficient for BAEe is 840. 
0.15,  at pH 7.6.  Under these conditions,  the velocity of substrate hydrolysis 
bore a linear relationship to the quantity of enzyme added (Fig.  12).  At 25°C, 
1 mg of rabbit kallikrein hydrolyzed 51.4/zM BAEe/min. 
The hydrolysis of certain  synthetic  substrates,  not  conveniently measured 
by spectrophotometry, were observed by high voltage electrophoresis on paper. 
Aliquots of substrate alone or substrate to which 0.5 #g of kallikrein was added 
were subjected to electrophoresis at l, 3, and 5 hr (Fig. 13).  When the rates of 
hydrolysis were  compared,  the following rank  order was  observed: AGLMe, 
CBZLMe  >  BLMe, ALMe>  TLMe  >  LMe. ALA was not  cleaved under 
these conditions. 
Inhibition of Kallikrein.--The  effect  of  certain  trypsin  inhibitors  on  the 
esterolytic activity of rabbit kallikrein  is given in  Table IV. The  trypsin in- KIRK  D.  WUEPPER  AND  CHARLES  G.  COCHRANE  15 
hibitors diisopropyl fluorophosphate  (DFP),  Trasylol  (FBA Pharmaceuticals, 
New York) and SBTI were effective inhibitors  of kallikrein  at low molarity. By 
contrast, other inhibitors of trypsin, namely, LBTI, egg white trypsin inhibitor 
(OMTI), tolsyl lysine chloromethyl ketone (TLCK), and phenyl methyl sulfonyl 
fluoride  (PMSF), were not kallikrein  inhibitors.  Each inhibitor was separately 
tested with trypsin to verify its potency. 
Hydrolysis of Protein Substrates.--After prolonged incubation of protein solu- 
tions with kallikrein,  small quantities of TCA-soluble 125I-labeled peptides were 
released from albumin (2.5 %), gamma globulin (2.0%),  or hemoglobin  (< 1%). 
By contrast, 61% of labeled gamma globulin was TCA soluble after incubation 
with trypsin under identical conditions. 
FIG.  13. High voltage electrophoresis of synthetic substrates incubated with buffer or plasma 
kallikrein for 5 hr at room temperature. 
DISCUSSION 
The importance of these investigations of prekallikrein  in rabbit plasma are 
as follows. (a) The glycoprotein was isolated from other members of the kinin- 
forming system and purified  approximately 6000-fold.  The final product was 
free from detectable contaminants,  yielding a single band in polyacrylamide- 
disc electrophoresis.  (b) Only one prekallikrein  was found in plasma that could 
be  activated  by the  prekallikrein  activator  derived  from  purified  Hageman 
factor.  (c)  Prekallikrein  was activated by PKA  through  enzymatic cleavage 
into two polypeptide fragments measuring  88,000 and 11,000 daltons.  (d) The 
larger  fragment,  kallikrein,  behaved as a  trypsin-like  enzyme with restricted 
specificity. 16  PLASMA  PREKALLIKREIN 
The Kallikrein Precursor.--In early attempts to purify precursor components 
of  the kinin system, apparently spontaneous and complete activation of pre- 
kallikrein took  place.  The  diflSculty was  overcome by  use  of  plastic vessels 
throughout and pretreatment of  containers and  separatory media with  hexa- 
dimethrine bromide. Presumably, one  of the initial components of  the kinin- 
TABLE  IV 
Inhibition  of Rabbit Kallikrein  by Trypsin Inhibitors 
Substance  tested  Final concentration  BAEe hydrolysis*  Inhibition 
None 
DFP 
Trasylol 
SBTI 
moles~liter  m,unzoles/min  % 
--  196  -- 
1  X  10  -s  36  81 
5  X  10  -4  69  65 
2.5  X  10  -4  105  46 
1.25  X  10  -4  132  32 
2.5  X  10  -6  13  93 
1.25  X  10  -6  51  74 
6.25  X  10  -7  115  41 
3.12  X  10  -7  159  20 
2.5  X  10  -G  71  64 
1.25  X  10  -G  86  56 
6.25  X  10  -~  107  44 
3.12  X  10  -7  146  25 
LBTI  5  X  10  -a  192  2 
OMTI  5  X  10  -5  199  0 
TLCK  5  X  10  -5  199  0 
PMSF  5  X  10  -s  185  5 
* Initial velocity of 0.1 ml of kallikrein incubated  15 min with buffer or inhibitor 0.1 ml 
and assayed on m~ BAEe, pH 7.6, 25°C, # 0.15. 
forming system is  easily activated.  From the pioneer work of  Margolis  (14) 
and  Ratnoff  and  Miles  (15),  we  suspected  that  blood-clotting factor  XII 
(Hageman factor)  might be  the  labile or  easily  activated substance.  Hexa- 
dimethrine bromide was selected as a known inhibitor of the surface activation 
of Hageman factor (16, 17). Using the techniques described in this report and 
in abridged form elsewhere (11, 4), it has been possible to prepare prekallikrein 
consistently from rabbit and human plasma. 
Others have obtained a  partial purification of prekallikrein or a  mixture of KIRK  D.  WUEPPER  AND  CHARLES  G.  COCHRANE  17 
the  precursor  and  its  activated  moiety.  Prekallikrein  (kallikreinogen,  pro- 
kininogenase) has been partially purified from guinea pig serum and bovine 
plasma. Davies and Lowe (18)  and Davies, Holman, and Lowe (19) obtained 
guinea pig prekallikrein in semipurified form by a one-step method on DEAE- 
cellulose.  Their  final product  consisted  of  a  mixture  of  kallikrein  and  pre- 
kallikrein. The activity was augmented by incubation with aged albumin-rich 
serum  fractions.  Nagasawa  et  al.  purified  bovine  plasma  prekallikrein  by 
chromatography on DEAE- and CM-Sephadex. The bovine prekallikrein was 
specifically activated by bovine Hageman factor (20). 
Characterization  of  Prekallikrein.--The  proenzyme  behaved  as  a  single 
homogenous molecular species throughout all preparative and analytical tech- 
niques. The molecular weight of the precursor was estimated by three methods. 
There was close  agreement between the results  obtained by molecular sieve 
chromatography (98,000-102,000  daltons), by calculation from sedimentation 
and diffusion rates (99,900 daltons), and by SDS-acrylamide-gel electrophoresis 
(98,000-106,000  daltons). Prekallikrein migrated in Pevikon at pH  8.1  with 
"yl-globulins. The electrophoretic mobility of prekallikrein in various supporting 
media was  in  keeping with  its  isoelectric point  measured  to  be  5.9-6.05  in 
polyampholytes. 
The periodic  acid-Schiff method was used  to detect  carbohydrate in pre- 
kallikrein after electrophoresis in SDS-acrylamide gels. A single PAS-positive 
band  was  found  at  the  same  relative  mobility  as  the  band  staining 
with Coomassie blue dye and with the peak of 125I label in cut gels (Rm 0.22). 
Rabbit prekallikrein is thus a glycoprotein. 
Comparison  of  Human  and  Rabbit  Prekallikrein.--We  have  applied  the 
methods described here to the isolation of human prekallikrein. The isolated 
proenzyme again corresponded to a small peak of protein migrating anodally 
to gamma globulin after electrophoresis in Pevikon similar to that in Fig. 3. 
After activation with human PKA, esterolytic activity corresponded exactly to 
this protein peak. In contrast to rabbit prekallikrein, human prekallikrein had 
a sedimentation coefficient of 5.2 S and a calculated mol wt of 107,000 by SDS- 
acrylamide gel electrophoresis. The isoelectric point was 7.7. After activation, 
there was  no observable difference  in  sedimentation coefficient or molecular 
weight. 
Other studies support the concept of a single kallikrein despite activation of 
the molecule in plasma.  Human plasma kallikrein, purified by Webster  (21) 
from acetone-activated plasma, appeared to be a single substance by its elution 
from DEAE-cellulose  and Amberlite IRC-50.  Porcine plasma kallikrein was 
investigated by Habermann and Klett (22). The isolated enzyme had a calcu- 
lated tool wt of 86,000 and migrated as a 3'i-3'2 globulin. The enzyme rapidly 
hydrolyzed BAEe (54/zg/min per mg) at 37°C. By contrast, Colman, Mattler, 
and Sherry (23),  in studies of/32-kallikrein in human plasma, described three 18  PLASMA  PREKALLIKREIN 
substances  behaving  as  a  kallikrein.  The  three  kallikreins  of  these  authors 
differed in  charge,  molecular weight,  and  their  capacity to  cleave synthetic 
esters. The possibility that at least two of the kallikreins were related was shown 
immunologically.  Our findings based on an analysis of the precursor prekallikrein 
in both rabbit and human plasma revealed only one kallikrein in plasma, cor- 
responding most closely to kallikrein I  of Colman et at. (23). 
The Activation of Prekallikrein.--We believe the present report provides the 
first  direct  evidence  that  prekallikrein is  activated  by  a  process  of  limited 
proteolysis. This conclusion is based on the finding of distinct physical changes 
in the molecule upon activation and upon the appearance of a split fragment. 
An increased diffusion coefficient,  decreased  average Stoke's radius,  and de- 
creased sedimentation coefficient were found to accompany activation. Treat- 
ment  of  highly  purified  prekallikrein,  radiolabeled  with  125I, with  the  pre- 
kallikrein activator resulted in cleavage of the molecule into two labeled frag- 
ments. The fragments were resolved by gradient ultracentrifugation, gel filtra- 
tion, and SDS-acrylamide-gel electrophoresis. The parent molecule was found 
to be cleaved into fragments of approximately 88,000 and 11,000 daltons. The 
larger fragment possessed  kallikrein activity. The biologic  importance of the 
smaller fragment is being investigated currently. 
Additional evidence supporting the postulation that prekallikrein is activated 
by limited proteolysis stems from an analysis of its activator, PKA. PKA has 
been isolated and characterized in this and other laboratories (4, 11, 12, 24-26). 
As will be reported in detail separately, PKA is a  2.6S  acidic pseudoglobulin 
with an isoelectric point of 4.6 and a calculated mol wt of 31,800 daltons. We 
have recently isolated the precursor of the prekallikrein activator directly from 
human and rabbit plasma (27). In agreement with the findings of Kaplan and 
Austen (24, 28),  this molecule was identified as Hageman factor (27). The en- 
zymatic nature of PKA was supported by:  (e)  the effect of temperature and 
substrate concentration of the kinetics of its activation of prekallikrein (29); 
(b) its inhibition by DFP and certain trypsin inhibitors; and (c) ability to hy- 
drolyze synthetic amino acid esters. 
Kallikrein  Substrales  and  Inhibitors.--Kallikrein  generated  from  isolated 
rabbit prekallikrein hydrolyzed esters of N-substituted lysine or arginine. In- 
deed,  rabbit  kallikrein hydrolyzed BAEe  (92  #moles/min per  nlg)  at  37°C 
more efficiently than trypsin (31 #moles/min per rag). However, the action of 
purified kallikrein was restricted. This was best demonstrated by the finding 
that  kallikrein failed to  liberate  substantial  peptides  from gamma  globulin 
while trypsin cleaved large amounts of peptides in the same period of incuba- 
tion. 
The spectrmn of substances inhibitory for kallikrein was restricted to  the 
trypsin inhibitors,  DFP,  SBTI,  and Trasylol. Four other  trypsin inhibitors, 
LBT1, OMTI, TLCK, and PMSF, were without effect on kallikrein. Rabbit KIRK D.  WUEPPER AND CHARLES G.  COCHRANE  19 
kallikrein is thus a  trypsin-like enzyme of restricted specificities for substrates 
and inhibitors. 
SUMMARY 
The precursor of the kinin-forming enzyme, prekallikrein,  was isolated from 
rabbit  plasma protected  from activation  during preparatory procedures.  Pre- 
kallikrein  was shown to be a  4.5S 3,1-glycoprotein with  an isoelectric point of 
5.9 and a mol wt of 99,900. The proenzyme was activated at neutral pH by an 
enzyme from rabbit or human plasma we have termed prekallikrein  activator 
(PKA)  or  by  trypsin.  Prekallikrein  was  activated  by  PKA  by  a  process  of 
enzymatic scission. This resulted in the appearance of two fragments; the larger 
of these possessed kallikrein activity. 
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